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E-mail address: stoccogc@unipa.it (G. Stocco).Novel diorganotin(IV) derivatives of L-Arginine (HArg), Na-(tert-Butoxycarbonyl)-L-Arginine (Boc–Arg–
OH) and L-Ala-L-Arg (H2Ala–Arg), H2NC(@NH)NH(CH2)3CH(NHR0)CO2H, where R0 = H in HArg,
R0 = C(O)OC(CH3)3 in Boc–Arg–OH, R0 = H2NCH(CH3)CO in H2Ala–Arg and triorganotin(IV) derivatives of
Boc–Arg–OH have been synthesized and structurally characterized. The complexes were investigated
by FT-IR and 119Sn Mössbauer in the solid state and by 1H, 13C, 119Sn and 1H–1H COSY NMR spectroscopy,
in solution. The spectroscopic characterization leading to the proposed molecular structures was accom-
plished on the basis of these experiments. L-Arginine appears to behave as a chelating ligand through car-
boxylate and -NH2 groups in Me2Sn(Arg)2, while in Na-t-Boc-L-Arginine complex, the Na-protected amino
group being exempted from coordination, only the carboxylate groups are effectors of bonding to the
organometallic moieties. FT-IR spectra give a clear indication that guanidino groups in all the complexes
are not involved in coordination, since m(C@N–H) frequency of the terminal guanidino group is fairly con-
stant and unshifted relative to the free ligand. The biological activity of organotin(IV)-complexes was also
investigated by use of human HT29 colorectal carcinoma cells. The cytotoxic activity of the compounds
was determined by the MTT quantitative colorimetric assay, capable of detecting viable cells in compar-
ison with that exerted by cisplatin. A marked cytotoxic activity for nearly all complexes, is evident being
higher than that exerted by cisplatin, while no signiﬁcant improvement of activity was observed for
Me2Sn(Arg)2 and Me2Sn(Ala–Arg), which was conﬁrmed by IC50 values. Then, we assessed whether the
cytotoxicity induced by organotin(IV) complexes was associated with the induction of apoptosis. Light
microscopy analysis, performed to study the morphological changes induced in HT29 cells, conﬁrmed
the results obtained with MTT test. No signiﬁcant morphological alterations were observed in HT29
cells after treatment with Me2Sn(Ala–Arg) and Me2Sn(L-Arg)2. Cells treated with nBu2Sn(Boc–Arg)2,
nBu2Sn(Ala–Arg),
nBu3Sn(Boc–Arg) and Me3Sn(Boc–Arg), appeared rounded, isolated and detached from
culture substrate, indicating the commitment to apoptotic cell death.
 2009 Elsevier B.V. All rights reserved.1. Introduction reactive domain represented by an antitumor active organometal-Proteomics, besides elucidating the cellular functions of pro-
teins in both normal and pathological processes, is applied in tar-
get identiﬁcation and drug discovery [1]. Selection of a suitable
target whose biological activity can be directly linked to a patho-
logical process is the ﬁrst step in the development of new small
molecule therapeutics. In the ﬁeld of complexes of organometallic
ions with proteins (or simple aminoacids and peptides) the task of
combining in one molecule a DNA binding moiety (peptide) and aAll rights reserved.
himica Inorganica e Analitica
elle Scienze, 90128 Palermo,lic moiety, is strongly appealing. Moreover, the imposition by (org-
ano)metallic ions of conformational constraints on peptidic ligands
can possibly lead to molecules whose structure acts as a template
orienting side chains in such a way that they act as recognition ele-
ments towards a receptor substrate.
Tethered oligoarginine conjugates, where the peptide is at-
tached to a rhodium or ruthenium intercalator, bind and with
photoactivation selectively cleave DNA. The presence cell-pene-
trating peptide oligoarginine is found to increase the nonspeciﬁc
binding afﬁnity of functionalized intercalator for both matched
and mismatched DNA [2,3].
The aim of this work is to synthesize complexes of Arginine,
effector of recognition, with organotin(IV) ions (R2Sn2+ and R3Sn+,
R = Me, nBu) which are known to possess antitumour [4],
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essential aminoacid with a side-chain guanidino group, which is
strongly basic and protonated in a wide range of pH values and
serves as a biological recognition site through hydrogen bonding
[7]. Molecular recognition, enzymatic reactions and protein struc-
tures are connected with the properties of arginine. Recognition of
DNA for initiation of DNA transcription, as in Zinc ﬁnger domain,
are exerted by arginine [8]. A literature review [9] demonstrates
that L-Arginine, the only substrate of the NO production, affects
cardiovascular system (blood vessels and heart); Arg residues,
e.g. Arg376 and Arg182 called as ‘‘arginine ﬁnger”, have a profound
effect on synthetic or hydrolytic processes of ATP in the rotational
mechanism of F0F1-ATPase [10]. Moreover, experiments performed
‘‘in vivo” and ‘‘in vitro” also suggest that L-Arginine may have a
complex antiaggregatory, anticoagulatory and proﬁbrinolytic ef-
fect. Therefore, a novel therapeutic potential of L-Arginine should
be taken into consideration [11].
Recently, interests in organotin(IV) carboxylates are increasing
due to their possible medical uses as antitumor agents [12]. Novel
organotin(IV) complexes of L-Arginine (HArg), Na-t-Boc-Arginine
(Boc–Arg–OH) along with complexes with the dipeptide, L-Ala-
nyl-L-Arginine (H2Ala–Arg) were synthesized. In all the complexes,
the ligand is expected to be the recognition determinant of the
specimen towards DNA, while the organometallic moieties, which
are known to possess antitumor activity [13], might show an in-
creased biological activity. The Arg-Gly-Asp (RGD) tripeptide se-
quence has been identiﬁed as a major cell adhesion recognition
motif, in this context it appears that protection of the amino termi-
nal group of RGD by Boc increases the inhibition of secondary
cataract versus unprotected RGD [14].2. Experimental
2.1. Materials and methods
nBu2SnO and nBu3SnOCH3 (Aldrich), Me3SnOH (Alfa Aesar), L-
Arginine and Na-t-Boc-L-Arginine (Fluka) and L-Ala-L-Arg (Bachem)
were used without further puriﬁcation. Methanol was distilled
over magnesium and benzene dried according to the literature.
Me2SnO was obtained by hydrolysis of Me2SnCl2 dissolved in water
by treatment with 25%(w/w) aqueous ammonia solution. Elemen-
tal microanalyses for C, H and N were carried out by the Laborato-
rio di Microanalisi, University of Padova, Italy.
Thermogravimetric measurements were performed from room
temperature to 800 C, with a Mettler TA-4000 system operating
in a pure nitrogen atmosphere.
The Mössbauer (nuclear c resonance) spectrometers, the related
instrumentation and data reduction procedures were as previously
described [15]. A 10 mCi Ca119SnO3 source (RITVERC GmbH, St.
Petersburg, Russia) was employed. The isomer shifts (d) are relative
to room temperature Ca119SnO3. Infrared spectra (nujol mulls, CsI
windows) were recorded with an FT-IR spectrometer Perkin-Elmer
Spectrum One. 1H, 13C spectra in CD3OD, DMSO-d6 and D2O, were
recorded at 298 K with Bruker Avance 300 operating at 300 MHz
for 1H and at 63 MHz for 13C. 119Sn NMR experiments were carried
out at 298 K at 111.92 MHz in CD3OD solution with a spectral
width of 400 ppm. 1H and 13C resonances were calibrated on tetra-
methylsilane as reference. For 119Sn NMR spectra, in CD3OD,
tetramethyltin(IV) was employed as external reference.2.2. Biological studies
2.2.1. Chemicals and reagents
Stock solutions of the compounds were prepared in DMSO and
just prior to treatment freshly diluted in the culture medium. Theﬁnal concentration of DMSO never exceeded 0.1% which is a con-
centration that was experimentally determined to have no discern-
ible effect on employed cell line.
2.2.2. Cell lines and culture conditions
Human colon-rectal carcinoma HT29 cells were cultured in
RPMI 1640 medium, supplemented with 10% (v/v) heat-inactivated
fetal calf serum (FCS) and 2.0 mM glutamine, at 37 C in a humid-
iﬁed atmosphere containing 5% CO2. In order to assess cell growth
and morphology, 104 cells/well were seeded in 96-well plates.
After plating, cells were allowed to adhere overnight and then trea-
ted with the compounds or with the same amount of DMSO em-
ployed as vehicle (control cells).
2.2.3. Cell viability assay
The effect of the compounds on cell viability was determined by
the MTT quantitative colorimetric assay [16]. This method is based
on the reduction of the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT) into purple formazan by mitochon-
drial dehydrogenases of living cells. Dye absorbance in viable cells
was measured at 570 nm with 630 nm as a reference wavelength,
using an ELISA microplate reader (OPSYS MR, Dynex Technologies)
against lysis buffer as a blank. Values reported in Fig. 7a are ex-
pressed as the percentage of the viability with respect to vehicle-
treated control cells. All experiments were repeated at least ﬁve
times and each experimental condition was repeated in triplicate
wells in each experiment.
2.3. Synthesis
The reaction of R2SnO (R = Me, nBu) with HL = HArg and Boc–
Arg–OH, H2L = H2Ala–Arg in a 1:2 and 1:1 molar ratio, Me3SnOH/
nBu3SnOCH3 with HL = Boc–Arg–OH, led to the formation of the
complexes according to Eqs. (1)–(3), respectively:
R2SnOþ 2HL! R2SnðLÞ2 þH2O; ð1Þ
R2SnOþH2L! R2SnðLÞ þH2O; ð2Þ
R3SnOH=R3SnOCH3 þHL! R3SnðLÞ þH2O=CH3OH: ð3Þ2.3.1. Me2Sn(L-Arg)2 (1)
A solution ofMe2SnO (0.329 g, 2 mmol) in benzenewas added to
a solution of HArg (0.697 g, 4 mmol) in hot methanol. The mixture
was reﬂuxed for 4 h. The solutionwas ﬁltered on a sintered glass ﬁl-
ter and the white solid washed with dichloromethane and stored in
a vacuum dessicator. C14H32N8O4Sn (1); dec. 189 C; M = 495.17 g/
mol; Anal. Calc.: C, 33.96; H, 6.51; N, 22.63. Found: C, 33.70; H,
7.17; N, 21.96%. IR data (CsI, cm1): 3341 msh, 3263m, 3087m
m(NH); 1679s m(C@NH); 1645s mas(COO), 1422m ms(COO),
Dm = 224; 586m mas(Sn–C), 516w ms(Sn–C); 436m m(Sn–N). 119Sn
Mössbauer data: d = 1.08, DE = 2.69, C± = 0.90 mm s1.
2.3.2. nBu2Sn(Boc–Arg)22H2O (2) Me2Sn(Ala–Arg)0.5H2O (5)
A solution of Bu2SnO (0.497 g, 2 mmol) or Me2SnO (0.329 g,
2 mmol) in dry methanol was added to a solution of Boc–Arg–OH
(1.097 g, 4 mmol) or H2Ala–Arg (0.491 g, 2 mmol), in dry methanol.
The mixture was reﬂuxed for 4 h. The solvent was reduced under
vacuum to a small volume; an oil was obtained in both cases which
gave a white solid product when dried in vacuo and washed with a
a mixture of methanol/petroleum ether (1:3, v/v). C30H64N8O10Sn
(2); m.p. 159–162 C. M = 815.60 g/mol; Anal. Calc.: C, 44.18; H,
7.91; N, 13.74. Found: C, 44.02; H, 8.12; N, 12.96%. Selected IR data
(CsI, cm1): 3346m, 3163m m(NH); 1608s m(C@NH) + mas(COO),
1393m ms(COO), Dm = 247; 595m mas(Sn–C); 565m ms(Sn–C).
119Sn Mössbauer data: d = 1.00, DE = 2.11, C± = 0.81 mm s1.
C11H27N5O4Sn (5); dec. 194 C. M = 401.06 g/mol; Anal. Calc.: C,
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lected IR data (CsI, cm1): 3343mbr, 3172mbr m(NH); 1612sbr
m(C@NH) + mas(COO), 1403m ms(COO), Dm = 209; 568m mas(Sn–
C); 530m ms(Sn–C). 119Sn Mössbauer data: d = 1.08, DE = 2.69,
C± = 0.90 mm s1.2.3.3. nBu2Sn(Ala–Arg)1.5H2O (6)
A solution of nBu2SnO (0.497 g, 2 mmol) in dry methanol
(20 mL) was added to a methanolic solution of H2Ala–Arg
(0.491 g, 2 mmol); the mixture was reﬂuxed for 4 h. The excess
of solvent was reduced under vacuum to a small volume and the
white solid precipitated by addition of diethyl ether, which was ﬁl-
tered off, washed with diethyl ether and dried in vacuo.
C17H39N5O4Sn (6); m.p. 109–112 C. M = 512.24 g/mol; Anal. Calc.:
C, 40.58; H, 7.61; N, 13.92. Found: C, 40.18; H, 7.56; N, 13.20%. Se-
lected IR data (CsI, cm1): 3341mbr, 3172mbr, 3076mbr m(NH);
1608sbr m(C@NH) + mas(COO), 1402m ms(COO), Dm = 206;
582m mas(Sn–C); 537w ms(Sn–C). 119Sn Mössbauer data: d = 1.19,
DE = 2.80, C± = 0.79 mm s1.2.3.4. Me3Sn(Boc–Arg)CH3OH (3) and nBu3Sn(Boc–Arg)CH3OH (4)
A solution of Boc–Arg–OH (0.549 g, 2 mmol) in dry methanol
(20 mL) was added to a solution Me3SnOH (0.362 g, 2 mmol) or
nBu3SnOCH3 (0.642 g = 0.56 ml, 2 mmol). After stirring the solu-
tion overnight, the excess of solvent was reduced under vacuum
to a small volume in a rotary evaporator, a thick oil was obtained
in both cases. These were treated with diethyl ether and petro-
leum ether and white solids were formed. The complexes were
washed with a mixture of methanol/petroleum ether (1:3 v/v).
C14H32N4O5Sn (3); m.p. 119–122 C. M = 469.17 g/mol; Anal.
Calc.: C, 38.40; H, 7.30; N, 11.94. Found: C, 37.94; H, 7.00; N,
11.57%. Selected IR data (CsI, cm1): 3343sbr, 3164sbr m(NH);
1683sbr m(C@NH); 1631m mas(COO), 1406m ms(COO),
Dm = 225; 545m mas(Sn–C); 512w ms(Sn–C). 119Sn Mössbauer data:
d = 1.25, DE = 3.08, C± = 0.91 mm s1. C24H52N4O5Sn (4); m.p.
144–147 C. M = 595.41 g/mol; Anal. Calc.: C, 48.41; H, 8.80; N,
9.41. Found: C, 47.89; H, 8.66; N, 10.07%. Selected IR data (CsI,
cm1): 3344sbr, 3221mbr, 3090mbr m(NH); 1683 sbr m(C@NH);
1627mbr mas(COO), 1417m ms(COO); Dm = 207; 513m mas(Sn–C).
119Sn Mössbauer data: d = 1.38, DE = 3.11, C± = 1.14 mm s1.
Several attempts to crystallize this compound in suitable form
for the X-ray analysis failed. In absence of structural data, the coor-
dination environment of the tin center is indicated on the basis of
infrared and Mössbauer spectra [17].Fig. 1. Structure of Me2Sn(L-Arg)2.3. Results and discussion
3.1. Solid state studies
3.1.1. IR spectra and Mössbauer data
The IR spectra of the complexes have been examined in compar-
ison with the spectra of the free ligands. The X-ray structure of
L-Arg dihydrate and infrared spectra including assignments have
been reported [18,19]. The structures of the organotin(IV) com-
plexes of the amino acids and dipeptide raise the question: which
are the coordination sites to the tin atom (amino group nitrogen,
carboxyl oxygen atoms and peptidic N–H or carbonyl groups),
which coordination numbers result from these interactions and
the detailed coordination geometry about the tin atom. The isomer
shift (d) data are typical of organotin(IV) derivatives [20,21]. The
narrowness of the linewidths, C, suggests the occurrence of single
tin sites in each compound.3.1.2. Complex with L-Arginine
The position of m(N–H) bands the amino groups is inﬂuenced by
hydrogen bonding and by coordination of the nitrogen to tin. Coor-
dinated amino groups show a substantial lowering of the N–H
stretching frequencies along with an enhancement of their
intensities.
The ligand exists in a zwitterionic form, in the solid state [22].
Vibrational frequencies associated with coordinated NH2 group,
in Me2Sn(L-Arg)2, show a shift to lower frequencies relative to
the free ligand indicating coordination of the amino group to the
central tin atom. Two bands typical of stretching m(N–H) of primary
amines are detected at 3341 and 3263 cm1. The asymmetric
vibration mas(COO) is consistently shifted to higher frequencies
in Me2Sn(L-Arg)2 (1), mas(COO) band at 1618 cm1 in the free li-
gand shifts to 1645 cm1, while the symmetric ms(COO) remains
at the same value. Mössbauer spectrum of Me2Sn(L-Arg)2 (1) is
characterized by a quadrupole splitting value which is typical of
both tetrahedral and cis-R2 octahedral structures, but the cis-R2
octahedral structure (Fig. 1) may be inferred since the aminoacid
coordinates to the tin atom through the carboxylate and the amino
groups.3.1.3. Complexes with Na-(tert-Butoxycarbonyl)-L-Arginine
Inhibition of coordinating ability of the protected amino group
(-NH-Boc) in a, which is consistent with its lower basicity, is
evidenced by a band at 3344 cm1 in the IR spectra of Na-t-Boc-
L-Arg, which remains unaltered in nBu2Sn(Boc–Arg)2 (2), Me3Sn
(Boc–Arg) (3) and nBu3Sn(Boc–Arg) (4) indicating Boc group’s
non-involvement in coordination. The m(C@NH) vibration which
is present in the spectra of the ligands HArg and Boc–Arg–OH (at
1679 cm1 and 1681 cm1, respectively) and assigned [19] to the
guanidyl group appears unaffected in the spectra of the amino acid
complexes reported above, indicating lack of involvement of the
guanidinic group in coordination to the organometallic ion. A car-
boxylate ion, RCO2 , can coordinate to metal ions in a number of
ways, as a unidentate ligand, as a chelating ligand, as a bridging
bidentate ligand or as a monatomic bridging ligand, either alone
with additional bridging or in arrangement involving chelation
and bridging. For the triorganotin(IV) derivatives, mas(COO) vibra-
tion is shifted to a small extent in the opposite direction. Dm
[Dm = mas(COO)  ms(COO)] value for nBu2Sn(Boc–Arg)2 (2) is
247 cm1, and larger than in the free ligands, which suggests
that carboxylate groups are coordinating in a monodentate
fashion [23]. A different pattern is presented in the case of the
triorganotin(IV)-Boc–Arg derivatives, were Dm = 225 cm1 and
Dm = 207 cm1 are signiﬁcantly less than the free ligand value
(Dm = 243 cm1). Mössbauer spectrum of nBu2Sn(Boc–Arg)2 (2) is
characterized by quadrupole splitting value [DE = 2.11 mm s1]
which is typical of both cis-R2 octahedral and tetrahedral struc-
tures. The tetrahedral arrangement is foreseeable for compound
nBu2Sn(Boc–Arg)2, in which the tin atom is unidentately coordi-
Fig. 3. Structure of R2Sn(Ala–Arg) where R = Me, nBu.
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tives of aminoacids are generally characterized by polymeric struc-
tures with carboxylate groups bridging planar R3Sn units [24]. D
values for such compounds are in the range 3.3–3.9 mm s1. Dis-
crete structures, with unidentate coordination of the carboxylate
group, are normally adopted by triphenyl- or tricyclohexyltin(IV)
derivatives as a consequence of the steric hindrance of the organic
groups. Such compounds show D values ranging from 2.3 to
3.0 mm s1. The D values of Me3Sn(Boc–Arg) [DE = 3.08 mm s1]
and nBu3Sn(Boc–Arg) [DE = 3.11 mm s1], ﬁt well with the litera-
ture data for monomeric, distorted tetrahedral structures
(Fig. 2b) taking into account that the partial quadrupole splitting
of the alkyl group is larger than that of the phenyl group. In such
case, discrete structures would be imposed by the steric hindrance
of the ligand which bears the large Boc substituent on the a-amino
group.3.1.4. Complexes with L-Alanyl-L-Arginine
In the diorganotin(IV) complexes of dipeptide H2Ala–Arg, infor-
mation on the occurrence of metal coordination by the basic atoms
of the amide group may be obtained from the infrared frequencies
of the modes amide I [m(C@O)] and amide II [m(CN) + d(NH)] [17].
The zwitterionic forms of the dipeptides in the solid state pres-
ent asymmetric and symmetric COO stretching vibrations, which
are shifted to higher frequencies, in the complexes. In Me2Sn(Ala–
Arg) (5) and nBu2Sn(Ala–Arg) (6) the broad bands at 1612 cm1 and
1608 cm1, respectively, probably arise from the overlap of amide I
which is shifted to lower frequencies and mas(COO) bands relative
to the vibrations in the free ligand at 1635 cm1 and 1548 cm1.
The IR data support the notion that the dipeptide chelate the
metal ion, bonding through the terminal amino and carboxylate
groups and a deprotonated peptide nitrogen, yielding pentacoordi-
nated tin(IV) complexes, forming ﬁve-membered rings (Fig. 3),
while no evidence is offered for the involvement of the side-chain
(guanidyl) donor atoms in bonding. Further, the Mössbauer quad-
rupole splitting measured for compounds Me2Sn(Ala–Arg)
[DE = 2.69 mm s1] and nBu2Sn(Ala–Arg) [DE = 2.80 mm s1] are
consistent with the cis-R2 trigonal-bipyramidal structures [25].
Relative to the Mössbauer structural investigations in the solid
state, due to the high electronegativity of oxygen and nitrogenFig. 2. Structure of (a) nBu2Sn(Boc–Arg)2 (atoms, the Q.S. is mainly governed by \C–Sn–C bond angle [26].
The \C–Sn–C bond angle has been calculated by using Parish’s
relationship: Q.S. = 4[R][1 – (3/4)sinh]½, where h = \C–Sn–C and
[R] is partial splitting (p.q.s.) for alkyl groups bonded to tin, the re-
ported p.q.s. value for alkyl groups being 1.03 mms1, closely re-
lated to those reported for diorganotin(IV) derivatives of
dipeptides. The experimental D values for structurally character-
ized dialkyltin(IV) derivatives are spread over a wide range, from
2.5 to 3.2 mm s1, and the observed trends appear to be essentially
correlated to the \C–Sn–C bond angle which correspondently var-
ies from 123 to 144. The comparison of the data obtained in this
work with those reported in the literature led us to estimate the
\C–Sn–C bond angles of compounds (5) and (6) which resulted
approximately 125 and 130.
The geometry of the di- and triorganotin(IV) group may be re-
lated to the tin–carbon stretching modes which occur in the
600–500 cm1 region of the infrared spectra [17]. Two vibrational
modes, mas(Sn–C) and ms(Sn–C), due to a signiﬁcantly distorted tri-
gonal-planar SnC3 structure are present in Me3Sn(Boc–Arg) (3)
complex. In Me2Sn(Arg)2 (1), the presence of both mas(Sn–C) and
ms(Sn–C) bands suggests a bent C-Sn-C fragment. For the dipeptide
complexes, Me2Sn(Ala–Arg) (5) and nBu2Sn(Ala–Arg) (6), the pres-
ence of both vibrations, is consistent with the proposed trigonal
bipyramidal structure.
3.2. TGA analysis
The thermal decomposition of the synthesized complexes
nBu2Sn(Boc–Arg)2H2O, Me3Sn(Boc–Arg)CH3OH, nBu3Sn(Boc–Arg)b) R3Sn(Boc–Arg) where R = Me, nBu.
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investigated by thermogravimetry (TGA) and differential TGA
(DTG) techniques to identify the attached solvent molecules, in
order to conﬁrm the proposed stoichiometry and to support the
conclusions of the various spectroscopic techniques [27]. Thermo-
gravimetric analyses were performed from room temperature to
800 C. No solvent molecule was found for Me2Sn(Arg)2. Me3Sn-
(Boc–Arg)CH3OH undergoes a mass loss of 6.58% in the 30.20–
110.80 C range corresponding to the 6.82% value expected for
1 mol CH3OH and nBu3Sn(Boc–Arg)CH3OH undergoes a mass loss
of 5.74% (calculated 6.04%) in the range 67.43–101.89 C for
1 mol CH3OH per formula unit.
The percent weight loss for nBu2Sn(Boc–Arg)2H2O is 3.63% (cal-
culated 4.41%) in the range 24.64–118.71 C corresponding to
2 mol of water and for nBu2Sn(Ala–Arg)1.5H2O is 5.01% (calculated
5.27%) in the range 32.34–139.22 C for the latter corresponding to
1.5 mol water.
In Me2Sn(Ala–Arg)0.5H2O complex the mass loss 2.51% (calcu-
lated 2.24%) in the range 32.33–139.22 C is equivalent to 0.5 mol
of water per formula unit. The residue obtained was, in all cases,
SnO2, as evidenced by FT-IR spectrum and tin content. The temper-Table 1
1H chemical shiftsa (d) for ligands and di- and triorganotin(IV) complexes.
Compound (solvent) d (ppm)a
L-Arg (D2O) H-2: 3.76 (t,1H); H-3: 1.89 (dt, 2H); H-4: 1.66 (m, 2H);
1 Me2Sn(L-Arg)2 (D2O) H-2: 3.32(t, J = 5.9, 1H); H-3+ H-4: 1.72–1.51 (m, 4H); H
Boc–Arg (CD3OD) H-2: 3.97 (t, J = 5.8, 1H); H-5 + H-6: 1.73–1.54 (m, 3H)c;
(br,1H):, NH2Arg: 7.04 (br, 2H)
2 Bu2Sn(Boc–Arg)2
(CD3OD)
H-2: 3.93 (t, J = 6.1, 1H); H-5 + H-6: 1.86–1.70 (m,br, 4H);
H-c: 1.35(m, 4H); H-d: 0.92(dt, 6H)
4 Bu3Sn(Boc–Arg)
(CD3OD)
H-2: 3.92 (t, J = 5.8, 1H); H-5 + H-6: 1.58 (m, br, 4H); H-
H-c:1.32(q, 4H); H-d = 0.88 (t, J = 7.3, 9H)
Boc–Arg (DMSO-d6) H-2: 3.62 (t, J = 6.1, 1H); H-5 + H-6: 1.70–1.43 (m,4H)c; H
4 Bu3Sn(Boc–Arg)
(DMSO-d6)
H-2: 3.65 (dt, 1H); H-5 + H-6: 1.69–1.42 (m, 4H); H-7: 3.
4H); H-b: 1.52 (dd, 4H); H-c: 1.26 (dd, J = 14.6 Hz, 7.3 H
Boc–Arg (D2O) H-2: 3.88 (br, 1H); H-5 + H-6: 1.67–1.30 (m, br, 4H); H-
3 Me3Sn(Boc–Arg)
(D2O)
H-2: 3.90 (t, 1H); H-5 + H-6: 1.63 (m,br, 4H); H-7: 3.20
Ala–Arg (CD3OD) H-2: 4.23 (t, 1H); H-3: 1.84 (dd, 2H), 1.72 (dd, 2H); H-4: 1
3H)
5 Me2Sn(Ala–Arg)
(CD3OD)
H-2: 4.21 (t, J = 5.5 Hz, 1H); H-3: 1.77 (dd, 2H), 1.64 (dd
J = 7.0 Hz, 1H); H-9: 1.42 (d, J = 7.0 Hz, 3H); H-a1: 0.81 [
[78.0 Hz]b h2 = 128.5
6 Bu2Sn(Ala–Arg)
(CD3OD)
H-2: 4.20 (t, J = 5.5, 1H); H-3: 1.67 (m, 4H); H-4: 1.59 (q,
J = 7.0, 4H); H-b = 1.54 (m, 4H); H-c = 1.38(m, 4H); H-d:
5 Me2Sn(Ala–Arg)
(DMSO-d6)
H-2: 3.88 (t, J = 5.1 Hz, 1H); H-3: 1.76 (dd, 2H), 1.60 (dd,
(d, J = 7.0 Hz, 3H); (NH2Ala + NH2 guanidyl + N-H guanid
h2 = 128.9; H-a2: 0.55 [79.0 Hz]b h1 = 129.6
6 Bu2Sn(Ala–Arg)
(DMSO-d6)
H-2: 3.87 (t, J = 5.1 Hz, 1H); H-3: 1.77 (dd, 2H), 1.57 (dd, 2
3.39 (dd, J = 14.0, 7.0, 1H); H-9: 1.28 (d, 3H); H-b + H-c =
(br, 5H); H-a = 1.09 (t, J = 7.0, 4H); H-d: 0.88 (dt, J = 11.4
Abbreviations: s, singlet; d, doublet; dd, double doublet; t, triplet; dt, double triplet; m,
6
1
NH
O
NH 2
NH2
NH2
5 3
4
OH
8NH NH
NH2
7
6
O
Arg Boc-ArgL-
a In ppm from TMS.
b 2J(119Sn,1H) and 2J(117Sn,1H) = coupling constants and hn = C–Sn–C bond angle [31].
c Overlapping of 1CH2 (Boc–Arg) + 2 CH (Boc–Arg) [11].
d Boc = tert-Butoxycarbonyl.atures at which the water molecules have been lost, rule out any
involvement in coordinating the tin(IV) atom, therefore water mol-
ecules could be involved in hydrogen bonding in the complexes.
4. Solution state studies
4.1. 1H and 13C NMR spectra
The resonances for the individual amino acids were assigned
according to Wüthrich [28] and literature data [11]. Structural
information for the complexes in solution has been acquired by
1H, 13C, 119Sn and 1H–1H COSY spectra. In Table 1 1H N.M.R. spectra
are reported for the free ligands and the complexes. Solubility for
all specimen was very poor in all solvents and the goal of obtaining
concentrations higher than 103 mol/L proved to be frustrating.
4.2. R2Sn(IV)
2+ complexes with L-Arginine
For the Me2Sn(Arg)2 complex surprisingly solubility was larger
in D2O than in DMSO. Relative to the free zwitterionic form of the
ligand, all resonances are shifted to higher ﬁeld on complexation asH-5: 3.23 (t, 2H)
-5: 3.18 (t, J = 6.5, 2H); H-a: 0.66 [82.5 Hz]b h1 = 134.1; [78.9 Hz]b h2 = 129.5
H-5: 1.80 (m, 1H); H-7: 3.18 (t, J = 6.1, 2H); Boc d: 1.43(s, 9H); NHArg: 7.70
H-7: 3.14 (t, J = 6.3, 2H); Bocd: 1.40(s, 9H); H-a: 1.25 (m, 4H); H-b:1.66 (dd, 4H);
7: 3.13 (t, J = 6.7, 2H); Bocd: 1.38(s, 9H); H-a:1.09(t, 4H); H-b:1.55 (t, 4H);
-7: 3.03 (t, 2H); Bocd: 1.36(s) (m, 9H); NHArg: 7.61 (br,1H):, NH2Arg: 7.40 (br, 2H)
04 (t, J = 6.5, 2H); Bocd: 1.36(s, 9H); NHArg + NH2Arg: 7.65 (br, 3H); H-a: 1.10 (t,
z, 4H); H-d: 0.96 (t, 9H)
7: 3.18 (t, 2H); Bocd: 1.40(s, 9H)
(t, 2H); Bocd: 1.42(s, 9H); H-a: 0.42 (s, 9H) [64.2 Hz]b, h1 = 115.0
.62 (q, 2H); H-5: 3.17 (t, 2H); H-8: 3.84 (q, J = 7.0 Hz, 1H); H-9: 1.44 (d, J = 7.0 Hz,
, 2H); H-4: 1.52 (q, 2H); H-5: 3.19 (dd, J = 15.5 Hz, 7.8 Hz, 2H); H-8: 3.57 (q,
81.0 Hz]b h1 = 132.2; [75.0 Hz]b h2 = 125.0; H-a2: 0.70 [84.0 Hz]b h1 = 130.6;
2H); H-5: 3.22 (dd, 2H); H-8: 3.48 (q, J = 7.0, 1H); H-9: 1.43 (d, 3H); H-a = 1.17 (t,
0.93(dt, J = 12.2 Hz, 7.3 Hz, 6H)
2H); H-4: 1.45 (q, 2H); H-5: 3.00 (dd, J = 7.0 Hz, 2H); H-8: 3.37 (q, 1H); H-9: 1.28
yl): 8.92 (br, 1H), 7.90 (br, 5H); H-a1: 0.67 [80.8 Hz]b h1 = 131.9; [78.5 Hz]b
H); H-4: 1.45 (dd, J = 10.2 Hz, J = 7.6 Hz, 2H); H-5: 3.00 (dd, J = 13.9, 7.2, 2H);H-8:
1.40–1.18 (m, 8H); (NH2Ala + NH2 guanidyl + N-H guanidyl): 8.86 (br, 1H), 7.82
Hz, 7.2 Hz, 6H)
multiplet; q, quartet; sbr, singlet broad.
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complexes. L-Arginine conformation has been reported as a partly
folded extended state of the zwitterionic form of the basic amino
acid with the positive charge distributed equally over three side
chain nitrogen atoms in its planar guanidinium group in aqueous
solution [30], hence both resonances for b-CH2 and c-CH2 are pres-
ent at 1.89 ppm and 1.66 ppm, respectively. While sharpness of
resonances rules out ligand exchange for the complex in solution,
the appearance of closely spaced resonances for both CH2 groups,
can be due to a modiﬁed conformation of the coordinate ligand
where the guanidyl group is present, relative to the free aminoacid,
leading to the equivalence of b-CH2 and c-CH2.
As for the coordination of the organometallic moiety, a single
resonance is present at 0.66 ppm. Lockhart and Manders’ relation-
ship [31] between C–Sn–C bond angles and 2J can be applied.
2J(119Sn, 1H) being 82.5 Hz, a C–Sn–C bond angle of 134.1 was cal-
culated. The dramatic difference between C–Sn–C bond angle in
the solid state and solution phase, is accounted by the larger
mobility of complex molecule in aqueous solution relative to the
solid state.
In Me2Sn(Arg)2 complex, 13C NMR in D2O, resonances due to the
carboxylate groups are shifted to higher frequencies relative to the
free ligand, while guanidyl C@NH resonance along with resonances
of the alkyl groups appear to be virtually unshifted with the nota-
ble exception of a-CH which are shifted to higher ﬁeld by 2 ppm
and b-CH2 by 1 ppm in the opposite direction. These data agree
with coordination by carboxylate and amino groups to the organo-
metallic moiety as in the solid state.
4.3. R2Sn(IV)
2+ and R3Sn(IV)
2+ with Na-(tert-butoxycarbonyl)-L-
Arginine
Coordination of di- and triorganotin(IV), with Na-t-Boc–Argi-
nine (Boc–Arg–OH) has been investigated to monitor the effect of
reduced basicity of the a-amino group and potential coordinating
ability of the guanidyl group. In Tables 1 and 2, 1H and 13C NMR rel-
evant resonances for the complexes are presented along with those
of the free ligand for comparison. NMR resonances of nBu2Sn(Boc–Table 2
13C chemical shiftsa (d) for ligands and di- and triorganotin(IV) complexes.
Compound (solvent) d (ppm)
L-Arg (D2O) C-1: 177.2; C-2: 57.1; C-3: 30.3; C-4: 25.1; C-5: 41.6
1 Me2Sn(L-Arg)2 (D2O) C-1: 181.9; C-2: 55.8; C-3: 30.9; C-4: 24.7; C-5: 41.3;
Boc–Argb (CD3OD) C-1: 179.7; C-2: 56.7; C-3: 157.9; Cquat-4: 80.2; C-5: 3
2 Bu2Sn(Boc–Arg)2
(CD3OD)
C-1: 179.4; C-2: 56.6; C-3: 157.8; Cquat-4: 80.3; C-5: 31
C-d: 14.2
3 Bu3Sn(Boc–Arg)
(CD3OD)
C-1: 179.3; C-2: 56.4; C-3: 157.8; Cquat-4: 80.3; C-5: 31
C-d: 14.2
2 Bu2Sn(Boc–Arg)2
(DMSO-d6)
C-1: 175.7; C-2: 54.6; C-3: 157.3; Cquat-4: 77.4; C-5: 3
C-d: 13.9
3 Bu3Sn(Boc–Arg)
(DMSO-d6)
C-1: 175.8; C-2: 54.5; C-3: 157.3; Cquat-4: 77.4; C-5: 30
C-d: 13.7
Boc–Arg (D2O) C-1: 179.3; C-2: 55.6; C-3: 156.8; Cquat-4: 81.0; C-5: 2
4 Me3Sn(Boc–Arg) (D2O) C-1: 179.9; C-2: 56.0; C-3: 157.3; Cquat-4: 81.2; C-5: 2
Ala–Arg (CD3OD) C-1: 178.3; C-2: 55.8; C-3: 31.1; C-4: 26.4; C-5: 42.2;
5 Me2Sn(Ala–Arg)
(CD3OD)
C-1: 180.0; C-2: 56.4; C-3: 31.7; C-4: 25.9; C-5: 42.3;
6 Bu2Sn(Ala–Arg)
(CD3OD)
C-1: 180.2; C-2: 56.9; C-3: 31.8; C-4: 26.0; C-5: 42.2; C
27.9, 27.8; C-d: 14.1
Ala–Arg (DMSO-d6) C-1: 175.3; C-2: 53.2; C-3: 29.9; C-4: 25.2; C-5: 40.8;
5 Me2Sn(Ala–Arg)
(DMSO-d6)
C-1: 175.1; C-2: 54.4; C-3: 29.8; C-4: 24.0; C-5: 40.6;
6 Bu2Sn(Ala–Arg) (DMSO-
d6)
C-1: 175.7; C-2: 54.6; C-3: 30.1; C-4: 25.0; C-5: 40.5; C
26.1, 26.0; C-d: 13.5
Sn—CH3
a
; Sn—CH2
a
—CH2
b
—CH2
c
—CH3
d
a In ppm from TMS.
b Boc = tert-Butoxycarbonyl.Arg)2 in CD3OD show only minor shifts relative to the free ligand,
which is consistent with the coordination to the organometallic
moiety only through the carboxylate group. 119Sn NMR spectrum,
in CD3OD, was also acquired. The most remarkable aspect of this
spectrum at room temperature is the appearance of two resonance
signals at 168 and 170 ppm, which gives a clear indication of
pentacoordinated moieties. The signiﬁcant variance with the solid
state (Mössbauer) structural information (i.e. tetrahedral geome-
try), along with the lack of 2J derived C–Sn–C angle from the proton
NMR spectrum, stresses the relevance of the 119Sn NMR informa-
tion, clearly indicating an equilibrium between tetrahedral and
pentacoordinated carboxylate bonded specimen: monodentate
ligand¢ chelate ligand. nBu3Sn(Boc–Arg) in CD3OD shows the
equivalence of b-CH2 and c-CH2 in a multiplet centered at
1.58 ppm, with a remarkable upﬁeld shift following coordination.
The 1H–1H COSY spectrum of nBu3Sn(Boc–Arg) is reported in
Fig. 4. Me3Sn(Boc–Arg) in D2O showing a close similarity of reso-
nances with free ligand, suggests the bonding only of the carboxyl-
ate group to the organometallic moiety, and 13C NMR shows only
minor variations. The close similarity of resonances for free ligand
Boc–Arg–OH, nBu2Sn(Boc–Arg)2, Me3Sn(Boc–Arg) and nBu3Sn(Boc–
Arg) is possibly due to the extensive hydrogen bonding which is
expected to be present in all specimen.
4.4. R2Sn(IV)
2+ complexes with L-Alanyl-L-Arginine
The complexes under investigation are obtained by means of a
neutralization reaction leading to a variation of charge distribution
in arginine as evidenced in DMSO-d6 solution by 1H NMR spectra.
C@NH, (NH2Ala + NH2 guanidyl + N–H guanidyl) resonances are
present at 8.92 ppm, 1H, and 7.90 ppm, 5H, for Me2Sn(Ala–Arg);
at 8.86 and 7.82 ppm for nBu2Sn(Ala–Arg), indicating a novel con-
formation of the dipeptide, presumably adopting an extended con-
formation as suggested by Xian et al. [30]. The 1H–1H COSY spectra
of the Me2Sn(Ala–Arg) (5) and nBu2Sn(Ala–Arg) (6) are reported in
Figs. 5 and 6, respectively. As expected, the resonance due to pep-
tidic N–H is absent, since in the complex coordination takes place
with ionization of peptidic group. The solution behaviour of theC-a: 2.3
1.5; C-6: 26.5; C-7: 42.2; C-8: 158.9; C-Boc: 29.0
.8; C-6: 26.3; C-7: 42.3; C-8: 158.8; C-Boc: 28.9; C-a: 23.4; C-b: 29.1; C-c: 28.5;
.6; C-6: 26.4; C-7: 42.2; C-8: 158.8; C-Boc: 29.4; C-a: 16.9; C-b: 28.4; C-c: 26.4;
0.0; C-6: 25.2; C-7: 34.7; C-8: 154.8; C-Boc: 28.2; C-a: 18.6; C-b: 30.1; C-c: 25.2;
.1; C-6: 25.2; C-7: 41.4; C-8: 154.9; C-Boc: 28.3; C-a: 16.9; C-b: 27.5; C-c: 26.7;
8.9; C-6: 24.5; C-7: 40.7; C-8: 157.6; C-Boc: 27.6
9.3; C-6: 24.8; C-7: 41.3; C-8: 158.0; C-Boc: 28.1; C-a: 2.21
C-6: 158.9; C-7: 172.5; C-8: 50.8; C-9: 18.6
C-6: 158.8; C-7: 177.0; C-8: 52.1; C-9: 19.9; C-a: 0.6, 0.8
-6: 158.9; C-7: 177.3; C-8: 52.4; C-9: 21.3; C-a: 20.5, 20.1; C-b: 28.6, 28.4; C-c:
C-6: 157.4; C-7: 172.5; C-8: 50.1; C-9: 21.4
C-6: 157.3; C-7: 173.4; C-8: 50.1; C-9: 19.1; C-a: 0.4, 0.4
-6: 157.4; C-7: 173.6; C-8: 50.4; C-9: 18.4; C-a: 19.4, 19.3; C-b: 26.8, 26.7; C-c:
Fig. 4. 1H–1H COSY spectrum for nBu3Sn(Boc–Arg).
Fig. 5. 1H–1H COSY spectrum for Me2Sn(Ala–Arg).
Fig. 6. 1H–1H COSY spectrum for nBu2Sn(Ala–Arg).
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solvents) has been monitored and structural details, namely C–
Sn–C angles, obtained by evaluating 2J(119Sn, 1H) by use of Lockhart
and Manders’ relationship [31]. The C–Sn–C angle has been calcu-
lated for Me2Sn(Ala–Arg) (Table 1) both in DMSO-d6 and CD3OD
solvents and closely agrees with that found for the complex in
the solid state by use of the literal point-charge model, which clo-
sely supports the idea that a trigonal–bipyramidal structure is
present both in the solid phase and in solution. Me2Sn(Ala–Arg)
C–Sn–C bond angle closely agree with those reported for dimethyl-
tin-dipeptides obtained by us for Met–His [27], Trp–Ala, Trp–Trp
and His–Tyr complexes [32]. As for Met–His derivatives, the Ala–
Arg complexes reported in this work are examples of amphiphilicpeptide complexes. As bioactivity of proteins is depending on con-
formation, along with construction of ‘‘peptide-amphiphiles” cre-
ating novel biomaterials with distint protein-like structures
[33,34], it is tempting to suggest that this Ala–Arg complexes
may represent new leads for a class of amphiphilic organometallic
complexes.
Higher frequencies shifts of signiﬁcant value, are only observed
for a-H(ala) resonance of Me2Sn- and nBu2Sn-complexes in both
solvents, which gives an indication of involvement of alanine’s
amino group in coordination to the organometallic moieties. For
the nBu2Sn(IV)-derivatives, diagnostic values of nJ(119Sn, 1H) cou-
pling constants could not with conﬁdence be evaluated which pre-
vented the acquisition of C–Sn–C bond angles.
Relative to the free dipeptide, the shifts of 13C NMR resonances
due to metal coordination have been monitored. A general pattern
emerges in the complexes, namely a shift to lower ﬁeld for arginine
(COO) group, alanine carbonyl peptidic (CO) group in CD3OD;
with the notable exception of the remaining 13C NMR resonances
which are virtually unshifted also in DMSO-d6, possibly due to
extensive hydrogen bonds in both free ligand and complexes. It
is noteworthy that in both solvents guanidyl C@NH resonance
being invariant, no evidence is given for involvement of this group
in bonding to the organometallic moiety. 13C and 1H NMR spectra
of Me2Sn(Ala–Arg) and nBu2Sn(Ala–Arg) in both solvents, present a
pattern which is peculiar for the several organotin(IV) dipeptide
complexes we previously investigated [27,32], namely, the chiral-
ity of the complexes is responsible for the appearance of two mag-
netically non-equivalent R2(Sn)-resonances.
Considering the conformation of the complexes both in the so-
lid state and in solution, as previously observed for arginine,
whereas in the free ligand the peptide backbone is predominantly
present in a ﬂexible extended form, in the complexes chelation by
amino, peptide nitrogens and carboxylate groups provides a stiff
backbone; therefore it is attached side-chain interactions which
play a crucial role in determining which conformation is preferred.
The 119Sn resonance in the 119Sn NMR spectra of Me2Sn(Ala–
Arg), recorded in CD3OD, exhibit a single chemical shift at
–120 ppm which is characteristic of pentacoordinated organo-
tin(IV) complexes with dipeptides [17]. Unfortunately, the scarce
Fig. 7. (a) Effects of organotin(IV)complexes or cisplatin on HT29 cell viability. Cells were treated for 24 h with the compounds, at the indicated concentrations. Cell viability
and IC50 value were estimated by MTT assay, as reported in Section 2.1. Results are expressed as the percentage of viable cells with respect to untreated controls. Data
represent the average ±SD of ﬁve independent experiments performed in triplicate. (b) IC50 values relative to the indicated compounds.
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Fig. 8. Morphological changes induced in HT29 cells by organotin(IV)-complexes or cisplatin treatment. Cells were treated for 24 h with 10 M of drugs and observed by light
microscopy. Data are representative of three independent experiments.
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suitable 119Sn NMR spectra.5. Biological studies
5.1. The effects of the organotin(IV)-complexes on HT29 cells viability
Scattered information is available on organotin(IV)-complexes
antitumor activity; a series of related derivatives of aminoacids
and peptides have been found to exhibit promising antiprolifera-
tive activity in vitro and in vivo [17,35]. All dimethyltin(IV) com-
pounds exhibit lower in vitro cytotoxic activity than di- and
tributyltin(IV) derivatives. This pattern is reproduced in the com-
pounds presented in this work. To examine the effects of organo-
tin(IV)-complexes, in comparison with that exerted by cisplatin,
on human HT29 colorectal carcinoma cells, monolayer cultures
were treated for 24 h with various concentrations (1–50 lM) of
the drugs and cell viability was evaluated by MTT assay (Fig. 7a)
to measure mitochondrial enzyme activity, as reported in Material
and Methods. All the compounds, except Me2Sn(Ala–Arg) which
results completely inefﬁcacious, clearly reduced cell viability in a
dose-dependent manner. Moreover, we observed that the cytotox-
icity trend was in the order nBu3Sn(Boc–Arg) > nBu2Sn(Boc–
Arg)2 > nBu2Sn(Ala–Arg) > Me3Sn(Boc–Arg), apparently butyl-
tin(IV)-derivatives have displayed higher activity following a gen-
eral behavior among organotins. For all these complexes, cytotoxic
activity was higher than that exerted by cisplatin, while that of
Me2Sn(L-Arg)2 was similar. For these compounds the maximum
reduction in cell viability (60–85%) was reached at the concentra-
tion of 50 lM. The comparison of IC50 values evidenced that Boc–
Arg complexes, and in particular the butyltin(IV) derivatives, were
the most efﬁcacious (Fig. 7b). Experiments performed to assay the
possible cytotoxicity of free ligands employed to synthesize the
organotin(IV)-complexes demonstrated that these ligands were
not able to exert any effect on HT29 cell viability (not shown). Light
microscopy analysis, performed to study the morphological
changes induced in HT29 cells by 24 h of treatment with 10 lM
of organotin(IV)-complexes or cisplatin, conﬁrmed the results ob-
tained with MTT test. In fact, as showed in Fig. 8, no evident mor-
phological alterations were observed in HT29 cells after treatment
with cisplatin, Me2Sn(L–Arg)2 and Me2Sn(Ala–Arg) whereas, when
treated with nBu2Sn(Boc–Arg)2, nBu2Sn(Ala–Arg), nBu3Sn(Boc–Arg)and Me3Sn(Boc–Arg), cells appeared rounded, isolated and de-
tached from culture substrate, indicating the commitment to apop-
totic cell death.
In conclusion, a tentative qualitative structure–activity relation-
ship indicates that butyltin(IV)-derivatives are more active than
dimethyltin(IV), and surprisingly Boc–Arg–OH derivatives being
more active than L-Ala-L-Arg in Bu2Sn-complexes.Acknowledgements
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